Compound ID | 246
Synonym(s): Omadacycline tosylate | PTK-0796 | Nuzyra
Class: Tetracycline
| Agent Type: | Semisynthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive & Gram-negative |
| Mechanism of action: | Protein synthesis inhibitor |
| Target Pathogen: | Active against pathogens causing bacterial pneumonia, acute bacterial skin and skin structure infections, and complicated urinary tract infections |
| Description: | Minocycline (aminomethylcycline) derivative; Flamm. R., Rhomberg. P., huband. M., Farrell. D. "Activity of Omadacycline Tested Against Streptococcus pneumoniae from a Global Surveillance Program (2014) " Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy. 2015. |
| Institute where first reported: | Paratek Pharmaceuticals, USA |
| Year first mentioned: | 2006 |
| Highest development stage: | Approved by FDA in 2018 |
| Development status: | Approved |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/54697325 |
| Guide to Pharmacology: | omadacycline |
| Citations: |
|
| Patent: | AU2021288202A1 |